Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of peginesatide for the
treatment of anemia in participants with chronic kidney disease who are on dialysis and are
not taking any treatment to increase their red blood cell production.